KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseExpense - Property Taxes and InsuranceExpense - Property and MaintenanceLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredReceivables - NetReceivables - OtherRevenue - Mortgage Backed SecuritiesRevenue - OtherRevenue - RentalShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

National Health Investors (NHI) Short-Term Debt repayments (2017 - 2026)

National Health Investors filings provide 10 years of Short-Term Debt repayments readings, the most recent being $35.0 million for Q1 2026.

  • On a quarterly basis, Short-Term Debt repayments fell 75.86% to $35.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $711.2 million, a 57.0% increase, with the full-year FY2025 number at $821.2 million, up 125.91% from a year prior.
  • Short-Term Debt repayments hit $35.0 million in Q1 2026 for National Health Investors, down from $85.0 million in the prior quarter.
  • In the past five years, Short-Term Debt repayments ranged from a high of $454.0 million in Q3 2025 to a low of $19.0 million in Q1 2023.
  • Median Short-Term Debt repayments over the past 5 years was $59.0 million (2022), compared with a mean of $97.7 million.
  • Biggest five-year swings in Short-Term Debt repayments: surged 817.17% in 2025 and later crashed 75.86% in 2026.
  • National Health Investors' Short-Term Debt repayments stood at $28.0 million in 2022, then soared by 46.43% to $41.0 million in 2023, then soared by 371.95% to $193.5 million in 2024, then tumbled by 56.07% to $85.0 million in 2025, then crashed by 58.82% to $35.0 million in 2026.
  • The last three reported values for Short-Term Debt repayments were $35.0 million (Q1 2026), $85.0 million (Q4 2025), and $454.0 million (Q3 2025) per Business Quant data.